Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-nr4z6 Total loading time: 0 Render date: 2024-06-08T12:03:38.967Z Has data issue: false hasContentIssue false

Chapter 11 - Posttransplant Lymphoproliferative Disorder

from Section III - Mature Lymphoid Neoplasm

Published online by Cambridge University Press:  25 November 2023

By
Xiayuan Liang
Edited by
Silvia Tse Bunting ,
Xiayuan Liang ,
Michele E. Paessler  and
Satheesh Chonat
Silvia Tse Bunting
Affiliation:
Cleveland Clinic Florida Weston
Xiayuan Liang
Affiliation:
University of Colorado
Michele E. Paessler
Affiliation:
University of Pennsylvania School of Medicine
Satheesh Chonat
Affiliation:
Emory University, Atlanta
Get access

Summary

Posttransplant lymphoproliferative disorders (PTLDs) comprise a heterogeneous category of lymphoid and plasmacytic proliferations occurring as a result of immunosuppression following solid organ or hematopoietic stem cell transplant [1–5]. PTLDs constitute a spectrum ranging from Epstein-Barr virus (EBV)-driven polyclonal proliferations to monoclonal EBV-positive or EBV-negative proliferations indistinguishable from a subset of B-cell lymphomas, T/natural killer (NK)-cell (less often) lymphomas, or classical Hodgkin lymphoma (cHL) (less often) that occur in immunocompetent individuals [1].

Type
Chapter
Information
Atlas of Pediatric Hematopathology , pp. 98 - 105
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Swerdlow, SH, Webber, SA, Chadburn, A, Ferry, LA. Post-transplant lymphoproliferative disorders. In Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Revised 4th ed. Lyon: IARC Press; 2017:453–62.Google Scholar
Abed, N, Casper, JT, Camitta, BM, Margolis, D, Trost, B, Orentas, R, Chang, CC. Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders. Bone Marrow Transplant. 2004 Feb; 33(3): 321–7.CrossRefGoogle ScholarPubMed
Nelson, BP, Nalesnik, MA, Bahler, DW, Locker, J, Fung, JJ, Swerdlow, SH. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: A distinct entity? Am J Surg Pathol. 2000 Mar 1; 24(3): 375–85.CrossRefGoogle ScholarPubMed
Liu, L, Zhang, X, Feng, S. Epstein-Barr virus-related post-transplantation lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2018 Jul; 24(7): 1341–9.CrossRefGoogle ScholarPubMed
Romero, S, Montoro, J, Guinot, M, Almenar, L, Andreu, R, Balaguer, A, et al. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation. Leukemia Lymphoma. 2019 Jan 2; 60(1): 142–50.CrossRefGoogle ScholarPubMed
Vakiani, E, Nandula, SV, Subramaniyam, S, Keller, CE, Alobeid, B, Murty, VV, Bhagat, G. Cytogenetic analysis of B-cell posttransplant lymphoproliferations validates the World Health Organization classification and suggests inclusion of florid follicular hyperplasia as a precursor lesion. Hum Pathol. 2007 Feb 1; 38(2): 315–25.CrossRefGoogle ScholarPubMed
Epperly, R, Ozolek, J, Soltys, K, Cohen, D, Goyal, R, Friehling, E. Treatment of pediatric plasma cell myeloma type post‐transplant lymphoproliferative disorder with modern risk‐directed therapy. Pediatr Blood Cancer. 2018 Oct; 65(10): e27283.CrossRefGoogle ScholarPubMed
Adams, H, Campidelli, C, Dirnhofer, S, Pileri, SA, Tzankov, A. Clinical, phenotypic and genetic similarities and disparities between post-transplant and classical Hodgkin lymphomas with respect to therapeutic targets. Expert Opin Ther Targets. 2009 Oct 1; 13(10): 1137–45.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×